More on SUWN
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Cash | |
| Accounts receivable, net of allowance for doubtful accounts of $1,253,628 and $1,098,240, respectively | |
| Accounts receivable - related party | |
| Notes receivable | |
| Inventories, net | 5.69M |
| Prepaid taxes | |
| Prepaid expenses and other current assets | 3.02M |
| Total Current Assets | 14.36M |
| Property and equipment, net | 9.05M |
| Land use rights | |
| Total Assets | 27.5M |
| Accounts payable and accrued expenses | |
| Taxes payable | |
| Derivative liability | |
| Total Current Liabilities | 11.14M |
| Common stock, $.001 par value, 200,000,000 shares authorized; 156,522,809 and 155,522,809 shares issued and outstanding | 199.63K |
| Additional paid-in capital | 37.68M |
| (Accumulated deficit) retained earnings | -26.05M |
| Accumulated other comprehensive income | 4.53M |
| Total Sunwin International Neutraceuticals, Inc. stockholders' equity | 16.36M |
| Noncontrolling interest | |
| Total Stockholders' Equity | |
| Total Liabilities and Stockholders' Equity | 27.5M |
